Drug intelligence / Profile preview

sIPV + tOPV

Development stage: Unknown
Modality: Vaccines & Immunotherapeutics
Administration: Intramuscular, Oral

Overview

This appears to be a combination of Sabin Inactivated Polio Vaccine (sIPV) and Trivalent Oral Polio Vaccine (tOPV). However, this specific combination is problematic as tOPV is no longer in use globally since April 2016 following the "OPV Switch." sIPV contains inactivated Sabin strains of poliovirus, while tOPV contained live attenuated strains of all three poliovirus types (1, 2, and 3). The combination would be unusual as these represent two different approaches to polio vaccination - one using killed virus (sIPV) and one using weakened live virus (tOPV).

Brand names: Candy

Targets

Neuraminidase

Beyond the preview

Go deeper on sIPV + tOPV.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on sIPV + tOPV.

Explore the full profile